Abstract
Many of the anomalous results obtained in the fibrinolytic assay of human plasmin systems were shown to be simply explained if bovine plasminogen had been introduced into the assay system on the addition of thrombin. Experimental investigation of the proteolytic and fibrinolytic activity of systems containing plasmin and thrombin showed that enzyme activity was influenced by the presence and quantity of thrombin. The quantity of bovine plasminogen present as a contaminant in bovine fibrinogen was shown to be responsible for only 1/25th of the observed enhanced activity. Thrombin in the amounts commonly used for clotting contained sufficient proenzyme to account for all this activity. A highly purified thrombin preparation obtained from another laboratory, and thrombin purified in this laboratory by starch electrophoresis brought about no enhancement of activity. The material separated from thrombin by starch electrophoresis was shown to be enzymatically identical with bovine plasminogen and, on labelling with radioactive iodine, was shown to behave physically like bovine plasminogen. Several experiments reported in the literature were reinterpreted in the light of this observation.
Full Text
The Full Text of this article is available as a PDF (797.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CHRISTENSEN L. R., SMITH D. H., Jr Plasminogen purification by acid extraction. Proc Soc Exp Biol Med. 1950 Aug;74(4):840–844. doi: 10.3181/00379727-74-18063. [DOI] [PubMed] [Google Scholar]
- CLIFFTON E. E., CANNAMELA D. Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma. J Appl Physiol. 1953 Jul;6(1):42–50. doi: 10.1152/jappl.1953.6.1.42. [DOI] [PubMed] [Google Scholar]
- FLETCHER A. P. The preparation of partially purified plasmin, and an account of its intrathecal use in patients. J Clin Invest. 1954 Sep;33(9):1242–1251. doi: 10.1172/JCI102999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GUEST M. M. Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject. J Clin Invest. 1954 Nov;33(11):1553–1559. doi: 10.1172/JCI103033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KLINE D. L. Studies on the purification and activation of plasminogen (profibrinolysin). Yale J Biol Med. 1954 Apr;26(5):365–371. [PMC free article] [PubMed] [Google Scholar]
- KLINE D. L. The purification and crystallization of plasminogen (profibrinolysin). J Biol Chem. 1953 Oct;204(2):949–955. [PubMed] [Google Scholar]
- PRESSMAN D., EISEN H. N. The zone of localization of antibodies. V. An attempt to saturate antibody-binding sites in mouse kidney. J Immunol. 1950 Apr;64(4):273–279. [PubMed] [Google Scholar]
- RATNOFF O. D. Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma. J Clin Invest. 1953 Jun;32(6):473–479. doi: 10.1172/JCI102762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
- SHERRY S. The fibrinolytic activity of streptokinase activated human plasmin. J Clin Invest. 1954 Jul;33(7):1054–1063. doi: 10.1172/JCI102973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WASSERMAN A. E. Streptokinase activation of a proteolytic enzyme in human blood. Arch Biochem Biophys. 1952 Nov;41(1):158–165. doi: 10.1016/0003-9861(52)90516-x. [DOI] [PubMed] [Google Scholar]